Skip to main content
Sofwave Medical Ltd. logo

Sofwave Medical Ltd. — Investor Relations & Filings

Ticker · SOFW ISIN · IL0011754392 TA Manufacturing
Open in API
Filings indexed 38 across all filing types
Latest filing 2024-05-09 Call Transcript
Country IL Israel
Listing TA SOFW

About Sofwave Medical Ltd.

https://sofwave.com

Sofwave Medical Ltd. is an aesthetic medical device company that develops and markets non-invasive energy-based solutions for skin rejuvenation and body contouring. The company's core technology, SUPERB™ (Synchronous Ultrasound Parallel Beam), utilizes high-frequency ultrasound to precisely heat mid-dermal tissue, stimulating the natural production of collagen, elastin, and hyaluronic acid. Its treatments are FDA-cleared for lifting the eyebrows, neck, and submental area, as well as improving fine lines, wrinkles, and the appearance of cellulite. The company also offers Pure Impact™, a bio-electrical muscle stimulation (EMS) technology for strengthening, toning, and firming muscles. Sofwave's solutions are designed to be safe for all skin types, offering clinically proven, natural-looking results with minimal downtime.

Recent filings

Filing Released Lang Actions
Presentation- Q1 2024 Summary-May 2024
Call Transcript Classification · 1% confidence The document text contains Hebrew characters and appears to be a regulatory filing or announcement, given the presence of dates (09/05/2024), reference numbers (515198158), and links to regulatory bodies (isa.gov.il, tase.co.il). Crucially, the text mentions a specific file name: 'Sofwave_Investor_earnings_call_May_2024_isa.pdf' and provides details about a scheduled event ('����� �� ���� ������ ������� �� �����: *09/05/2024* ����: *08:30*'). This strongly suggests an announcement related to an earnings call or investor event. Since the document itself is short (3243 chars) and seems to be announcing the availability or details of an earnings call/investor presentation rather than being the full transcript (CT) or the full earnings release (ER), it fits best as an Investor Presentation (IP) announcement or, more generally, a Report Publication Announcement (RPA) if it's just announcing the release of materials. Given the context of 'earnings_call' in the filename and the scheduled time, it is likely announcing the details of an upcoming event or the release of related materials. However, the structure, mentioning a specific file name and event time, aligns well with an announcement about investor materials. If the content were the full transcript, it would be 'CT'. If it were the summary results, it would be 'ER'. Since it's announcing the details/publication of materials related to an investor event, 'IP' (Investor Presentation) or 'RPA' are candidates. Given the explicit mention of an 'earnings_call' in the linked file name, and the structure being an announcement of details, 'RPA' (Report Publication Announcement) is the safest classification based on Rule 2, as it is announcing the publication/details of an event/report.
2024-05-09 Russian
Presentation- Investor Meeting-March 2024
Investor Presentation Classification · 1% confidence The document is titled 'Investor Meeting March 2024' and contains extensive slides detailing 2023 financial results (Revenues, GM, Cash position), strategic accomplishments, market trends, product pipeline updates (Sofwave Plus Pure Impact), and detailed financial tables for Q4 2023 and Full Year 2023 P&L. The content is highly comprehensive, covering performance review and outlook, which is characteristic of an Investor Presentation (IP) or a detailed Management Discussion and Analysis (MDA) often included within an Investor Presentation. Given the format (presentation slides) and the content focus (review of past performance, strategic updates, and financial highlights presented to investors), the most appropriate classification is Investor Presentation (IP). It is too detailed and structured to be a simple Earnings Release (ER) or a Report Publication Announcement (RPA).
2024-03-06 English
Presentation- Investor Meeting-March 2024
Regulatory Filings Classification · 1% confidence The document text is heavily garbled (appears to be Hebrew text encoded incorrectly or placeholder text), but several key structural elements and metadata points are visible or implied. 1. The document length is short (3219 chars), suggesting it might be an announcement rather than a full report (like a 10-K or IR). 2. It contains dates (06/03/2024, 2024-01-019651) and references to regulatory bodies/exchanges (www.isa.gov.il, www.tase.co.il). 3. Crucially, there is a line: "����� ���� *�����������������������2023_isa.pdf*" followed by a section indicating the publication time and date, and a link to a PDF file: "���� ����� ������� ������ ������". 4. This structure strongly suggests the document is an announcement *about* a report (the PDF) being published, rather than the report itself. 5. Based on the 'MENU VS MEAL' rule, this points towards a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). 6. Given the explicit mention of a report being published/attached/linked, RPA is the most specific fit among the announcement types.
2024-03-06 Russian
Presentation-Investor Meeting-November 2023
Investor Presentation Classification · 1% confidence The document is titled 'Investor Meeting November 2023' and contains detailed financial highlights for Q3 2023 and Q1-Q3 2023, including P&L statements and Balance Sheet data. It also includes extensive slides on market conditions, strategy, and product information, characteristic of a presentation given to investors. This format strongly suggests an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a brief earnings release (ER) as it is comprehensive. It is a presentation deck used for investor communication.
2023-11-08 English
Presentation-Investor Meeting-November 2023
Regulatory Filings Classification · 1% confidence The document text is heavily garbled (appears to be Hebrew text encoded incorrectly or placeholder text) but contains several key structural elements typical of a regulatory filing announcement. Specifically, it includes dates (e.g., 08/11/2023, 2023-01-122493), references to regulatory bodies/websites (www.isa.gov.il, www.tase.co.il), and explicit mentions of a file being attached or linked (e.g., "����� ���� *�����������������������������2023_isa.pdf*" and a hyperlink). The document length is short (3236 chars). According to Rule 2 (The 'Menu vs Meal' Rule), a short document announcing the publication of a report, rather than containing the full report content, should be classified as a Report Publication Announcement (RPA).
2023-11-08 Russian
Presentation -August 2023
Investor Presentation Classification · 1% confidence The document is titled 'Investor Meeting' and is dated 'August 2023'. It contains detailed financial highlights for Q2 2023 and H1 2023, including P&L statements and Balance Sheet data, along with strategic updates, market analysis, and investment highlights. This structure—a comprehensive presentation delivered to investors, summarizing recent performance and strategy—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER) which typically focuses only on the initial results announcement. Since it is a detailed presentation for investors, 'IP' is the most appropriate classification.
2023-08-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.